Frozen Shoulder Clinical Trials

Find Frozen Shoulder Clinical Trials Near You

Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to investigate the feasibility, usability and preliminary efficacy of a home-based Functional Electrical Stimulation(FES) in individuals with shoulder adhesive capsulitis. The main question it aims to answer is if combining home-based FES to usual therapy at the clinic will improve pain and improve function of the impaired shoulder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \> 18 years

• Individuals diagnosed with shoulder adhesive capsulitis

• Shoulder pain, limited shoulder mobility for more than 4 weeks, normal shoulder x-ray findings, and normal neurological exam

• Can tolerate electrical stimulation

Locations
United States
Maryland
University of Maryland School of Medicine, Baltimore, Maryland
RECRUITING
Baltimore
Contact Information
Primary
Sanjana Rao, PhD
sanjana.rao@som.umaryland.edu
4438256349
Time Frame
Start Date: 2026-06-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 10
Treatments
Other: Home-based FES
The intervention will include home use of Genesis Flex FES device alongside usual rehabilitation care. Participant education in Genesis FES use will be conducted during the baseline assessment session. FES parameters will be initially adjusted at the lowest possible current for patient comfort with the constraint that they should not elicit a tetanic contraction. FES will be provided via two self adhesive electrodes attached across shoulder joint.A shoulder harness adjustable neoprene padding will be provided to enable anatomical contouring for patient comfort and support for positioning of stimulator and electrodes to the affected shoulder.
Related Therapeutic Areas
Sponsors
Leads: University of Maryland, Baltimore

This content was sourced from clinicaltrials.gov